First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples